Early diagnosis of type 1 diabetes through autoantibody screening decreases the risk of critical illness and provides opportunities to use immunotherapy to delay disease progression. This talk will focus on Type1Screen and other local screening efforts and the ATIC consortium, which is running immunotherapy trials throughout Australia.